Lupin Purchases Instem Preclinical Software for Novel Drug Discovery & Development Program – Marketwatch

The Company today has significant presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, CNS, GI, Anti-Infectives and NSAID space in addition to holding global leadership positions in the Anti-TB and Cephalosporin segments. Lupin is …

Leave a Reply

Your email address will not be published.

*